Dopamine agonists in clinical research for new tardive dyskinesia treatments.
作者信息
Gerlach J, Casey D E
出版信息
Mod Probl Pharmacopsychiatry. 1983;21:97-110. doi: 10.1159/000408487.
PMID:6140637
Abstract
摘要
相似文献
1
Dopamine agonists in clinical research for new tardive dyskinesia treatments.用于新型迟发性运动障碍治疗的多巴胺激动剂的临床研究
Mod Probl Pharmacopsychiatry. 1983;21:97-110. doi: 10.1159/000408487.
2
Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.脱羧酶抑制作用以及多巴和3 - O - 甲基多巴水平：苄丝肼与卡比多巴在啮齿动物中的对比研究以及美多芭标准制剂与美多芭HBS在志愿者中的对比研究。
Eur Neurol. 1987;27 Suppl 1:9-20. doi: 10.1159/000116170.
3
Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia.
Psychopharmacol Bull. 1978 Oct;14(4):77-9.
4
[Treatment of patients with vascular parkinsonism with the preparations nakom and madopar].[使用纳科姆和美多芭制剂治疗血管性帕金森病患者]
Klin Med (Mosk). 1984 Apr;62(4):112-6.
5
Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
Adv Neurol. 1983;37:259-66.
6
Dopamine antagonist and agonist treatment of tardive dyskinesia.
Adv Biochem Psychopharmacol. 1980;24:541-5.
7
Comparison of levodopa with carbidopa or benserazide in parkinsonism.左旋多巴与卡比多巴或苄丝肼治疗帕金森病的比较。
Lancet. 1976 Aug 21;2(7982):381-4. doi: 10.1016/s0140-6736(76)92403-x.
8
Combined use of benserazide and carbidopa in Parkinson's disease.苄丝肼与卡比多巴联合用于帕金森病。
Neurology. 1984 Feb;34(2):227-9. doi: 10.1212/wnl.34.2.227.
9
Animal models of tardive dyskinesia: their use in the search for new treatment methods.
Mod Probl Pharmacopsychiatry. 1983;21:5-20. doi: 10.1159/000408479.
10
Response to Sinemet 25/100 in Parkinson's disease.帕金森病患者对息宁控释片25/100的反应
Adv Neurol. 1984;40:541-7.
Zotero 插件